Impact of Race on the Efficacy and Safety of Tofacitinib in Rheumatoid Arthritis: Post Hoc Analysis of Pooled Clinical Trials.

MLA

Wright, Grace C., et al. “Impact of Race on the Efficacy and Safety of Tofacitinib in Rheumatoid Arthritis: Post Hoc Analysis of Pooled Clinical Trials.” Rheumatology and Therapy, vol. 11, no. 5, Oct. 2024, pp. 1135–64. EBSCOhost, https://doi.org/10.1007/s40744-024-00677-y.

APA

Wright, G. C., Mysler, E., Kwok, K., Cadatal, M. J., Germino, R., Yndestad, A., Kinch, C. D., & Ogdie, A. (2024). Impact of Race on the Efficacy and Safety of Tofacitinib in Rheumatoid Arthritis: Post Hoc Analysis of Pooled Clinical Trials. Rheumatology and Therapy, 11(5), 1135–1164. https://doi.org/10.1007/s40744-024-00677-y

Chicago

Wright, Grace C, Eduardo Mysler, Kenneth Kwok, Mary Jane Cadatal, Rebecca Germino, Arne Yndestad, Cassandra D Kinch, and Alexis Ogdie. 2024. “Impact of Race on the Efficacy and Safety of Tofacitinib in Rheumatoid Arthritis: Post Hoc Analysis of Pooled Clinical Trials.” Rheumatology and Therapy 11 (5): 1135–64. doi:10.1007/s40744-024-00677-y.